Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Details

Connection

Judith Regensteiner to Peripheral Vascular Diseases

This is a "connection" page, showing publications Judith Regensteiner has written about Peripheral Vascular Diseases.

 
Connection Strength
  
 
 
2.607
  
  1. Regensteiner JG, Hiatt WR, Coll JR, Criqui MH, Treat-Jacobson D, McDermott MM, Hirsch AT. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Vasc Med. 2008 Feb; 13(1):15-24.
    View in: PubMed
    Score: 0.272
  2. Regensteiner JG, Stewart KJ. Established and evolving medical therapies for claudication in patients with peripheral arterial disease. Nat Clin Pract Cardiovasc Med. 2006 Nov; 3(11):604-10.
    View in: PubMed
    Score: 0.249
  3. Nehler MR, McDermott MM, Treat-Jacobson D, Chetter I, Regensteiner JG. Functional outcomes and quality of life in peripheral arterial disease: current status. Vasc Med. 2003 May; 8(2):115-26.
    View in: PubMed
    Score: 0.196
  4. Regensteiner JG, Ware JE, McCarthy WJ, Zhang P, Forbes WP, Heckman J, Hiatt WR. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc. 2002 Dec; 50(12):1939-46.
    View in: PubMed
    Score: 0.190
  5. Regensteiner JG, Hiatt WR. Current medical therapies for patients with peripheral arterial disease: a critical review. Am J Med. 2002 Jan; 112(1):49-57.
    View in: PubMed
    Score: 0.178
  6. Regensteiner JG, Hiatt WR. Treatment of peripheral arterial disease. Clin Cornerstone. 2002; 4(5):26-40.
    View in: PubMed
    Score: 0.178
  7. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg. 1996 Jan; 23(1):104-15.
    View in: PubMed
    Score: 0.118
  8. England JD, Ferguson MA, Hiatt WR, Regensteiner JG. Progression of neuropathy in peripheral arterial disease. Muscle Nerve. 1995 Apr; 18(4):380-7.
    View in: PubMed
    Score: 0.112
  9. Regensteiner JG, Hiatt WR. Exercise rehabilitation for patients with peripheral arterial disease. Exerc Sport Sci Rev. 1995; 23:1-24.
    View in: PubMed
    Score: 0.110
  10. Regensteiner JG, Hiatt WR. Medical management of peripheral arterial disease. J Vasc Interv Radiol. 1994 Sep-Oct; 5(5):669-77.
    View in: PubMed
    Score: 0.107
  11. Hiatt WR, Regensteiner JG. Nonsurgical management of peripheral arterial disease. Hosp Pract (Off Ed). 1993 Feb 15; 28(2):59-63, 67-70, 76-7 passim.
    View in: PubMed
    Score: 0.096
  12. Creager MA, Belkin M, Bluth EI, Casey DE, Chaturvedi S, Dake MD, Fleg JL, Hirsch AT, Jaff MR, Kern JA, Malenka DJ, Martin ET, Mohler ER, Murphy T, Olin JW, Regensteiner JG, Rosenwasser RH, Sheehan P, Stewart KJ, Treat-Jacobson D, Upchurch GR, White CJ, Ziffer JA, Hendel RC, Bozkurt B, Fonarow GC, Jacobs JP, Peterson PN, Roger VL, Smith EE, Tcheng JE, Wang T, Weintraub WS. 2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease). Circulation. 2012 Jan 17; 125(2):395-467.
    View in: PubMed
    Score: 0.089
  13. Creager MA, Belkin M, Bluth EI, Casey DE, Chaturvedi S, Dake MD, Fleg JL, Hirsch AT, Jaff MR, Kern JA, Malenka DJ, Martin ET, Mohler ER, Murphy T, Olin JW, Regensteiner JG, Rosenwasser RH, Sheehan P, Stewart KJ, Treat-Jacobson D, Upchurch GR, White CJ, Ziffer JA. 2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS Key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to develop Clinical Data Standards for peripheral atherosclerotic vascular disease). J Am Coll Cardiol. 2012 Jan 17; 59(3):294-357.
    View in: PubMed
    Score: 0.089
  14. Bronas UG, Hirsch AT, Murphy T, Badenhop D, Collins TC, Ehrman JK, Ershow AG, Lewis B, Treat-Jacobson DJ, Walsh ME, Oldenburg N, Regensteiner JG. Design of the multicenter standardized supervised exercise training intervention for the claudication: exercise vs endoluminal revascularization (CLEVER) study. Vasc Med. 2009 Nov; 14(4):313-21.
    View in: PubMed
    Score: 0.077
  15. Espeland MA, Regensteiner JG, Jaramillo SA, Gregg E, Knowler WC, Wagenknecht LE, Bahnson J, Haffner S, Hill J, Hiatt WR. Measurement characteristics of the ankle-brachial index: results from the Action for Health in Diabetes study. Vasc Med. 2008 Aug; 13(3):225-33.
    View in: PubMed
    Score: 0.070
  16. Murphy TP, Hirsch AT, Ricotta JJ, Cutlip DE, Mohler E, Regensteiner JG, Comerota AJ, Cohen DJ. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. J Vasc Surg. 2008 Jun; 47(6):1356-63.
    View in: PubMed
    Score: 0.069
  17. Mitchell RG, Duscha BD, Robbins JL, Redfern SI, Chung J, Bensimhon DR, Kraus WE, Hiatt WR, Regensteiner JG, Annex BH. Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral arterial disease. Vasc Med. 2007 Nov; 12(4):285-90.
    View in: PubMed
    Score: 0.067
  18. Haugen S, Casserly IP, Regensteiner JG, Hiatt WR. Risk assessment in the patient with established peripheral arterial disease. Vasc Med. 2007 Nov; 12(4):343-50.
    View in: PubMed
    Score: 0.067
  19. Hiatt WR, Klepack E, Nehler M, Regensteiner JG, Blue J, Imus J, Criqui MH. The effect of inhibition of acyl coenzyme A-cholesterol acyltransferase (ACAT) on exercise performance in patients with peripheral arterial disease. Vasc Med. 2004 Nov; 9(4):271-7.
    View in: PubMed
    Score: 0.054
  20. Regensteiner JG. Exercise rehabilitation for the patient with intermittent claudication: a highly effective yet underutilized treatment. Curr Drug Targets Cardiovasc Haematol Disord. 2004 Sep; 4(3):233-9.
    View in: PubMed
    Score: 0.054
  21. Rajagopalan S, Olin JW, Young S, Erikson M, Grossman PM, Mendelsohn FO, Regensteiner JG, Hiatt WR, Annex BH. Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease. Hum Gene Ther. 2004 Jun; 15(6):619-24.
    View in: PubMed
    Score: 0.053
  22. Falcone RA, Hirsch AT, Regensteiner JG, Treat-Jacobson D, Williams MA, Hiatt WR, Stewart KJ. Peripheral arterial disease rehabilitation: a review. J Cardiopulm Rehabil. 2003 May-Jun; 23(3):170-5.
    View in: PubMed
    Score: 0.049
  23. Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP. Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists. Circulation. 1995 Aug 01; 92(3):614-21.
    View in: PubMed
    Score: 0.029
  24. England JD, Regensteiner JG, Ringel SP, Carry MR, Hiatt WR. Muscle denervation in peripheral arterial disease. Neurology. 1992 May; 42(5):994-9.
    View in: PubMed
    Score: 0.023
  25. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med. 2002 Dec 12; 347(24):1941-51.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)